Characterization of Natural IL-6 Inhibition in Healthy Individuals — FIDI

Interleukin-6 Clinical Trial

Official title:
Characterization of Natural IL-6 Inhibition in Healthy Individuals

Status Recruiting

Clinical Trial Summary

The aim of the project is to investigate whether or not there are any difference in cardiometabolic outcomes in individuals with high or low levels of c-aAb against interleukin-6 (IL-6). The study is the first to investigate individuals with extreme amounts of c-aAb levels against IL-6 and to contribute with knowledge on a possible new phenotype.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05867524
Study type	Interventional
Source	University of Copenhagen
Contact	Torben Hansen, PhD
Phone	20565301
Email	torben.hansen@sund.ku.dk
Status	Recruiting
Phase	N/A
Start date	November 1, 2022
Completion date	February 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04544254` - Effectivity of Bilateral Transversus Thoracis Muscle Plane Block After Open Heart Surgery	N/A
Completed	`NCT03203343` - Inflammatory Stress Response in Pediatric Inguinal Hernia Repair	N/A
Completed	`NCT05057455` - Effectiveness of the Cytokine Hemadsorption on Sepsis
Recruiting	`NCT06238024` - Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment	Phase 2/Phase 3
Completed	`NCT05750160` - Music Therapy on Neutrophyl Lymphocytes Ratio, Interleukin 6 and Interleukin 10 Levels of Burnout Syndrome	N/A